A Single Amino Acid Change in Human O6-Alkylguanine-DNA Alkyltransferase Decreasing Sensitivity to Inactivation by O6-Benzylguanine

Una M. Crone, Anthony Pegg

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Mammalian O6-aIkylguanine-DNA alkyltransferases (AGTs) are readily inactivated by incubation with the pseudosubstrate, O6-benzylgua-nine, but the equivalent protein from the Escherichia coli ogt gene is much less sensitive and the Saccharomyces cerevisiae and E. coli ada gene product AGTs are completely resistant to this compound. We have expressed the normal human AGT and various point mutations (C145A, W100A, and P140A) in an ada- ogt- strain of E. coli and tested these proteins against DNA substrates containing O6-methylguanine, for inactivation by O6-benzylguanine and for the ability to produce guanine from O6-benzyl-guanine. The C145A mutation was inactive as expected since this residue forms the methyl acceptor site. Mutants W100A and P140A were fully active against methylated DNA substrates but the P140A mutant was much less sensitive to inactivation by Obenzylguanine and failed to form significant amounts of [3H] guanine when incubated with O6-benzy[8-3]-guanine. The proline at position 140 in mammalian AGTs is replaced by alanine in the Ada and yeast AGTs and by serine in the Ogt AGT. These results suggest that this proline residue affects the configuration of the active site allowing the O6-benzylguanine to enter and react with the mammalian AGT. The production of resistance to O6-benzylguanine by a single base change raises the possibility that such resistance may arise quite readily in cells of tumors treated therapeutically with the combination of O6-benzylguanine and an alkylating agent.

Original languageEnglish (US)
Pages (from-to)4750-4753
Number of pages4
JournalCancer Research
Volume53
Issue number20
StatePublished - Jan 1 1993

Fingerprint

Amino Acids
Guanine
Escherichia coli Proteins
Proline
Alkylating Agents
DNA
O(6)-benzylguanine
DNA alkyltransferase
Point Mutation
Alanine
Serine
Genes
Saccharomyces cerevisiae
Catalytic Domain
Yeasts
Escherichia coli
Mutation
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{901a120bb3904a558687a7e93a66f264,
title = "A Single Amino Acid Change in Human O6-Alkylguanine-DNA Alkyltransferase Decreasing Sensitivity to Inactivation by O6-Benzylguanine",
abstract = "Mammalian O6-aIkylguanine-DNA alkyltransferases (AGTs) are readily inactivated by incubation with the pseudosubstrate, O6-benzylgua-nine, but the equivalent protein from the Escherichia coli ogt gene is much less sensitive and the Saccharomyces cerevisiae and E. coli ada gene product AGTs are completely resistant to this compound. We have expressed the normal human AGT and various point mutations (C145A, W100A, and P140A) in an ada- ogt- strain of E. coli and tested these proteins against DNA substrates containing O6-methylguanine, for inactivation by O6-benzylguanine and for the ability to produce guanine from O6-benzyl-guanine. The C145A mutation was inactive as expected since this residue forms the methyl acceptor site. Mutants W100A and P140A were fully active against methylated DNA substrates but the P140A mutant was much less sensitive to inactivation by Obenzylguanine and failed to form significant amounts of [3H] guanine when incubated with O6-benzy[8-3]-guanine. The proline at position 140 in mammalian AGTs is replaced by alanine in the Ada and yeast AGTs and by serine in the Ogt AGT. These results suggest that this proline residue affects the configuration of the active site allowing the O6-benzylguanine to enter and react with the mammalian AGT. The production of resistance to O6-benzylguanine by a single base change raises the possibility that such resistance may arise quite readily in cells of tumors treated therapeutically with the combination of O6-benzylguanine and an alkylating agent.",
author = "Crone, {Una M.} and Anthony Pegg",
year = "1993",
month = "1",
day = "1",
language = "English (US)",
volume = "53",
pages = "4750--4753",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "20",

}

A Single Amino Acid Change in Human O6-Alkylguanine-DNA Alkyltransferase Decreasing Sensitivity to Inactivation by O6-Benzylguanine. / Crone, Una M.; Pegg, Anthony.

In: Cancer Research, Vol. 53, No. 20, 01.01.1993, p. 4750-4753.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A Single Amino Acid Change in Human O6-Alkylguanine-DNA Alkyltransferase Decreasing Sensitivity to Inactivation by O6-Benzylguanine

AU - Crone, Una M.

AU - Pegg, Anthony

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Mammalian O6-aIkylguanine-DNA alkyltransferases (AGTs) are readily inactivated by incubation with the pseudosubstrate, O6-benzylgua-nine, but the equivalent protein from the Escherichia coli ogt gene is much less sensitive and the Saccharomyces cerevisiae and E. coli ada gene product AGTs are completely resistant to this compound. We have expressed the normal human AGT and various point mutations (C145A, W100A, and P140A) in an ada- ogt- strain of E. coli and tested these proteins against DNA substrates containing O6-methylguanine, for inactivation by O6-benzylguanine and for the ability to produce guanine from O6-benzyl-guanine. The C145A mutation was inactive as expected since this residue forms the methyl acceptor site. Mutants W100A and P140A were fully active against methylated DNA substrates but the P140A mutant was much less sensitive to inactivation by Obenzylguanine and failed to form significant amounts of [3H] guanine when incubated with O6-benzy[8-3]-guanine. The proline at position 140 in mammalian AGTs is replaced by alanine in the Ada and yeast AGTs and by serine in the Ogt AGT. These results suggest that this proline residue affects the configuration of the active site allowing the O6-benzylguanine to enter and react with the mammalian AGT. The production of resistance to O6-benzylguanine by a single base change raises the possibility that such resistance may arise quite readily in cells of tumors treated therapeutically with the combination of O6-benzylguanine and an alkylating agent.

AB - Mammalian O6-aIkylguanine-DNA alkyltransferases (AGTs) are readily inactivated by incubation with the pseudosubstrate, O6-benzylgua-nine, but the equivalent protein from the Escherichia coli ogt gene is much less sensitive and the Saccharomyces cerevisiae and E. coli ada gene product AGTs are completely resistant to this compound. We have expressed the normal human AGT and various point mutations (C145A, W100A, and P140A) in an ada- ogt- strain of E. coli and tested these proteins against DNA substrates containing O6-methylguanine, for inactivation by O6-benzylguanine and for the ability to produce guanine from O6-benzyl-guanine. The C145A mutation was inactive as expected since this residue forms the methyl acceptor site. Mutants W100A and P140A were fully active against methylated DNA substrates but the P140A mutant was much less sensitive to inactivation by Obenzylguanine and failed to form significant amounts of [3H] guanine when incubated with O6-benzy[8-3]-guanine. The proline at position 140 in mammalian AGTs is replaced by alanine in the Ada and yeast AGTs and by serine in the Ogt AGT. These results suggest that this proline residue affects the configuration of the active site allowing the O6-benzylguanine to enter and react with the mammalian AGT. The production of resistance to O6-benzylguanine by a single base change raises the possibility that such resistance may arise quite readily in cells of tumors treated therapeutically with the combination of O6-benzylguanine and an alkylating agent.

UR - http://www.scopus.com/inward/record.url?scp=0027361505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027361505&partnerID=8YFLogxK

M3 - Article

C2 - 8402653

AN - SCOPUS:0027361505

VL - 53

SP - 4750

EP - 4753

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 20

ER -